Pyxis Oncology Inc.
PYXS | NASDAQ
$3.32
+$0.13 (+4.08%)
Sep 22, 2026, 1:36 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 11.04M | 13.86M | 13.86M | 2.82M | 2.82M | n/a | 16.15M | 16.15M | 16.15M | 16.15M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 27K | 27K | -432K | n/a | n/a | n/a | 475K | 475K | 475K | 475K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | 11.01M | 13.83M | 14.29M | 2.82M | 2.82M | n/a | 15.67M | 15.67M | 15.67M | 15.67M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Income | -92.11M | -85.87M | -84.42M | -106.19M | -106.49M | -106.77M | -89.46M | -67.16M | -68.76M | -66.85M | -82.2M | -102.4M | -105.44M | -113.05M | -123.48M | -101.93M | -85.16M | -65.38M | -69.72M | -57.87M | -49.44M | -46.06M |
Interest Income | 1.83M | 2.83M | 3.61M | 4.63M | 5.7M | 6.73M | 7.04M | 7.01M | 6.87M | 6.51M | 6.63M | 6.91M | 5.92M | 4.43M | 2.76M | 899K | 186K | 28K | 23K | 16K | 11K | 37.5K |
Pretax Income | -87.62M | -80.35M | -78.24M | -98.97M | -98.17M | -97.4M | -79.5M | -57.36M | -59.2M | -57.8M | -73.79M | -94.29M | -98.92M | -108.58M | -120.72M | -101.45M | -87.95M | -70.53M | -75.98M | -63.73M | -52.74M | -47.12M |
Net Income | -88.73M | -81.74M | -79.62M | -97.09M | -96.29M | -95.23M | -77.33M | -57.36M | -59.2M | -57.8M | -73.79M | -94.29M | -98.92M | -108.58M | -120.72M | -101.45M | -87.95M | -70.53M | -75.98M | -63.73M | -52.74M | -47.12M |
Selling & General & Admin | 24.51M | 20.02M | 21.51M | 21.36M | 22.4M | 23.04M | 25.42M | 26.5M | 31.15M | 31.8M | 32.61M | 34.57M | 33.26M | 35.09M | 37.35M | 38.43M | 32.85M | 27.03M | 18.66M | 10.9M | 7.9M | 5.98M |
Research & Development | 75.17M | 76.25M | 73.7M | 66.01M | 65.94M | 62.76M | 58.75M | 56.33M | 53.28M | 50.71M | 49.59M | 67.83M | 72.18M | 77.96M | 86.13M | 63.5M | 52.32M | 38.35M | 51.05M | 46.97M | 41.54M | 40.08M |
Other Expenses | 3.43M | 3.43M | 3.5M | 21.65M | 20.96M | 20.96M | 20.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 103.12M | 99.7M | 98.71M | 109.01M | 109.31M | 106.77M | 105.13M | 82.83M | 84.43M | 82.52M | 82.2M | 102.4M | 105.44M | 113.05M | 123.48M | 101.93M | 85.16M | 65.38M | 69.72M | 57.87M | 49.44M | 46.06M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | -684K | -684K | -684K | -684K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 103.14M | 99.72M | 98.28M | 109.01M | 109.31M | 106.77M | 105.61M | 83.3M | 84.9M | 82.99M | 82.2M | 102.4M | 105.44M | 113.05M | 123.48M | 101.93M | 85.16M | 65.38M | 69.72M | 57.87M | 49.44M | 46.06M |
Income Tax Expense | 1.1M | 1.39M | 1.39M | -1.88M | -1.88M | -2.16M | -2.16M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 63.99M | 63.47M | 62.14M | 62.56M | 61.92M | 61.05M | 60.72M | 60.72M | 60.5M | 51.29M | 44.75M | 41.33M | 38.39M | 35.35M | 34.96M | 32.56M | 32.45M | 32.32M | 31.73M | 31.73M | 31.73M | 22.13M |
Shares Outstanding (Diluted) | 63.99M | 63.47M | 62.14M | 62.56M | 61.92M | 61.05M | 60.72M | 60.72M | 60.5M | 51.29M | 44.75M | 41.33M | 38.39M | 35.35M | 34.96M | 32.56M | 32.45M | 32.32M | 31.73M | 31.73M | 31.73M | 22.13M |
EPS (Basic) | -1.41 | -1.31 | -1.29 | -1.58 | -1.58 | -1.57 | -1.28 | -1.05 | -1.26 | -1.38 | -1.82 | -2.50 | -2.77 | -3.14 | -3.61 | -3.11 | -2.73 | -2.21 | -2.90 | -2.58 | -2.27 | -4.75 |
EPS (Diluted) | -1.41 | -1.31 | -1.29 | -1.58 | -1.58 | -1.57 | -1.28 | -1.05 | -1.26 | -1.38 | -1.82 | -2.50 | -2.77 | -3.14 | -3.61 | -3.11 | -2.73 | -2.21 | -2.90 | -2.58 | -2.27 | -4.75 |
EBITDA | -83.44M | -75.93M | -73.72M | -78.17M | -77.17M | -76.35M | -57.88M | -54.24M | -56.29M | -54.95M | -71.86M | -92.87M | -97.81M | -107.84M | -120.01M | -100.77M | -87.31M | -69.84M | -74.23M | -61.97M | -50.88M | -45.49M |
EBIT | -87.62M | -80.35M | -78.24M | -80.34M | -79.54M | -78.77M | -60.87M | -57.36M | -59.2M | -57.8M | -73.79M | -94.29M | -98.92M | -108.58M | -120.72M | -101.45M | -87.95M | -70.53M | -74.88M | -62.63M | -51.65M | -46.06M |
Depreciation & Amortization | 4.18M | 4.42M | 4.51M | 2.17M | 2.37M | 2.42M | 2.98M | 3.12M | 2.91M | 2.85M | 1.93M | 1.43M | 1.11M | 741K | 709K | 675K | 634K | 692K | 647K | 659K | 769K | 567K |
Add to Watchlist
Select watchlists to add or remove PYXS